Market Access

The latest buzzword in pharma is "transparency"

A close look at the healthcare industry will separate real cost-cutting measures from money-saving myths.

The former health secretary offers a reality check on healthcare reform-and what to expect from the pols in '09

Congressional leaders ready campaign to curb Medicare drug plans.

A little-known provision in a new law rewards employees for blowing the whistle on tax fraud. Pharma should examine its tricky tax situation-and work out the issues on a global level.

The Medicare Modernization Act set the stage for rapid and easy conversion to government-controlled pricing and the adoption of government pricing by private payers.